Tuesday, January 11, 2022
After Biogen halved the price of its Alzheimers drug Medicare reevaluates its Part B premium hike. Omicron’s deluge on hospitals could be even worse than what’s being reported. And six former White House COVID advisors call for a new covid strategy.
The Gist Healthcare Podcast · Gist Healthcare Daily
January 11, 20226m 38s
Audio is streamed directly from the publisher (sphinx.acast.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
After Biogen halved the price of its Alzheimers drug Medicare reevaluates its Part B premium hike. Omicron’s deluge on hospitals could be even worse than what’s being reported. And six former White House COVID advisors call for a new covid strategy.
Hosted on Acast. See acast.com/privacy for more information.